Association of chromosome 19 to lung cancer genotypes and phenotypes

Xiangdong Wang, Yong Zhang, Carol L. Nilsson, Frode S. Berven, Per E. Andrén, Elisabet Carlsohn, Peter Horvatovich, Johan Malm, Manuel Fuentes, Ákos Végvári, Charlotte Welinder, Thomas E. Fehniger, Melinda Rezeli, Goutham Edula, Sophia Hober, Toshihide Nishimura, György Marko-Varga

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The Chromosome 19 Consortium, a part of the Chromosome-Centric Human Proteome Project (C-HPP, http://www.C-HPP.org), is tasked with the understanding chromosome 19 functions at the gene and protein levels, as well as their roles in lung oncogenesis. Comparative genomic hybridization (CGH) studies revealed chromosome aberration in lung cancer subtypes, including ADC, SCC, LCC, and SCLC. The most common abnormality is 19p loss and 19q gain. Sixty-four aberrant genes identified in previous genomic studies and their encoded protein functions were further validated in the neXtProt database (http://www.nextprot.org/). Among those, the loss of tumor suppressor genes STK11, MUM1, KISS1R (19p13.3), and BRG1 (19p13.13) is associated with lung oncogenesis or remote metastasis. Gene aberrations include translocation t(15, 19) (q13, p13.1) fusion oncogene BRD4-NUT, DNA repair genes (ERCC1, ERCC2, XRCC1), TGFβ1 pathway activation genes (TGFB1, LTBP4), Dyrk1B, and potential oncogenesis protector genes such as NFkB pathway inhibition genes (NFKBIB, PPP1R13L) and EGLN2. In conclusion, neXtProt is an effective resource for the validation of gene aberrations identified in genomic studies. It promises to enhance our understanding of lung cancer oncogenesis.

Original languageEnglish (US)
Pages (from-to)217-226
Number of pages10
JournalCancer and Metastasis Reviews
Volume34
Issue number2
DOIs
StatePublished - Jun 1 2015

Fingerprint

Chromosomes, Human, Pair 19
Lung Neoplasms
Genotype
Phenotype
Carcinogenesis
Genes
Oncogene Fusion
Lung
Comparative Genomic Hybridization
Human Chromosomes
Proteome
Tumor Suppressor Genes
Chromosome Aberrations
DNA Repair
Transcriptional Activation
Proteins
Databases
Neoplasm Metastasis

Keywords

  • Antibodies
  • Bioinformatics
  • Genes
  • Human disease
  • Mass spectrometry
  • mRNA
  • Protein microarray
  • Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wang, X., Zhang, Y., Nilsson, C. L., Berven, F. S., Andrén, P. E., Carlsohn, E., ... Marko-Varga, G. (2015). Association of chromosome 19 to lung cancer genotypes and phenotypes. Cancer and Metastasis Reviews, 34(2), 217-226. https://doi.org/10.1007/s10555-015-9556-2

Association of chromosome 19 to lung cancer genotypes and phenotypes. / Wang, Xiangdong; Zhang, Yong; Nilsson, Carol L.; Berven, Frode S.; Andrén, Per E.; Carlsohn, Elisabet; Horvatovich, Peter; Malm, Johan; Fuentes, Manuel; Végvári, Ákos; Welinder, Charlotte; Fehniger, Thomas E.; Rezeli, Melinda; Edula, Goutham; Hober, Sophia; Nishimura, Toshihide; Marko-Varga, György.

In: Cancer and Metastasis Reviews, Vol. 34, No. 2, 01.06.2015, p. 217-226.

Research output: Contribution to journalArticle

Wang, X, Zhang, Y, Nilsson, CL, Berven, FS, Andrén, PE, Carlsohn, E, Horvatovich, P, Malm, J, Fuentes, M, Végvári, Á, Welinder, C, Fehniger, TE, Rezeli, M, Edula, G, Hober, S, Nishimura, T & Marko-Varga, G 2015, 'Association of chromosome 19 to lung cancer genotypes and phenotypes', Cancer and Metastasis Reviews, vol. 34, no. 2, pp. 217-226. https://doi.org/10.1007/s10555-015-9556-2
Wang X, Zhang Y, Nilsson CL, Berven FS, Andrén PE, Carlsohn E et al. Association of chromosome 19 to lung cancer genotypes and phenotypes. Cancer and Metastasis Reviews. 2015 Jun 1;34(2):217-226. https://doi.org/10.1007/s10555-015-9556-2
Wang, Xiangdong ; Zhang, Yong ; Nilsson, Carol L. ; Berven, Frode S. ; Andrén, Per E. ; Carlsohn, Elisabet ; Horvatovich, Peter ; Malm, Johan ; Fuentes, Manuel ; Végvári, Ákos ; Welinder, Charlotte ; Fehniger, Thomas E. ; Rezeli, Melinda ; Edula, Goutham ; Hober, Sophia ; Nishimura, Toshihide ; Marko-Varga, György. / Association of chromosome 19 to lung cancer genotypes and phenotypes. In: Cancer and Metastasis Reviews. 2015 ; Vol. 34, No. 2. pp. 217-226.
@article{4575d56ae98840f6a3cf0839bf706853,
title = "Association of chromosome 19 to lung cancer genotypes and phenotypes",
abstract = "The Chromosome 19 Consortium, a part of the Chromosome-Centric Human Proteome Project (C-HPP, http://www.C-HPP.org), is tasked with the understanding chromosome 19 functions at the gene and protein levels, as well as their roles in lung oncogenesis. Comparative genomic hybridization (CGH) studies revealed chromosome aberration in lung cancer subtypes, including ADC, SCC, LCC, and SCLC. The most common abnormality is 19p loss and 19q gain. Sixty-four aberrant genes identified in previous genomic studies and their encoded protein functions were further validated in the neXtProt database (http://www.nextprot.org/). Among those, the loss of tumor suppressor genes STK11, MUM1, KISS1R (19p13.3), and BRG1 (19p13.13) is associated with lung oncogenesis or remote metastasis. Gene aberrations include translocation t(15, 19) (q13, p13.1) fusion oncogene BRD4-NUT, DNA repair genes (ERCC1, ERCC2, XRCC1), TGFβ1 pathway activation genes (TGFB1, LTBP4), Dyrk1B, and potential oncogenesis protector genes such as NFkB pathway inhibition genes (NFKBIB, PPP1R13L) and EGLN2. In conclusion, neXtProt is an effective resource for the validation of gene aberrations identified in genomic studies. It promises to enhance our understanding of lung cancer oncogenesis.",
keywords = "Antibodies, Bioinformatics, Genes, Human disease, Mass spectrometry, mRNA, Protein microarray, Proteins",
author = "Xiangdong Wang and Yong Zhang and Nilsson, {Carol L.} and Berven, {Frode S.} and Andr{\'e}n, {Per E.} and Elisabet Carlsohn and Peter Horvatovich and Johan Malm and Manuel Fuentes and {\'A}kos V{\'e}gv{\'a}ri and Charlotte Welinder and Fehniger, {Thomas E.} and Melinda Rezeli and Goutham Edula and Sophia Hober and Toshihide Nishimura and Gy{\"o}rgy Marko-Varga",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s10555-015-9556-2",
language = "English (US)",
volume = "34",
pages = "217--226",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Association of chromosome 19 to lung cancer genotypes and phenotypes

AU - Wang, Xiangdong

AU - Zhang, Yong

AU - Nilsson, Carol L.

AU - Berven, Frode S.

AU - Andrén, Per E.

AU - Carlsohn, Elisabet

AU - Horvatovich, Peter

AU - Malm, Johan

AU - Fuentes, Manuel

AU - Végvári, Ákos

AU - Welinder, Charlotte

AU - Fehniger, Thomas E.

AU - Rezeli, Melinda

AU - Edula, Goutham

AU - Hober, Sophia

AU - Nishimura, Toshihide

AU - Marko-Varga, György

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The Chromosome 19 Consortium, a part of the Chromosome-Centric Human Proteome Project (C-HPP, http://www.C-HPP.org), is tasked with the understanding chromosome 19 functions at the gene and protein levels, as well as their roles in lung oncogenesis. Comparative genomic hybridization (CGH) studies revealed chromosome aberration in lung cancer subtypes, including ADC, SCC, LCC, and SCLC. The most common abnormality is 19p loss and 19q gain. Sixty-four aberrant genes identified in previous genomic studies and their encoded protein functions were further validated in the neXtProt database (http://www.nextprot.org/). Among those, the loss of tumor suppressor genes STK11, MUM1, KISS1R (19p13.3), and BRG1 (19p13.13) is associated with lung oncogenesis or remote metastasis. Gene aberrations include translocation t(15, 19) (q13, p13.1) fusion oncogene BRD4-NUT, DNA repair genes (ERCC1, ERCC2, XRCC1), TGFβ1 pathway activation genes (TGFB1, LTBP4), Dyrk1B, and potential oncogenesis protector genes such as NFkB pathway inhibition genes (NFKBIB, PPP1R13L) and EGLN2. In conclusion, neXtProt is an effective resource for the validation of gene aberrations identified in genomic studies. It promises to enhance our understanding of lung cancer oncogenesis.

AB - The Chromosome 19 Consortium, a part of the Chromosome-Centric Human Proteome Project (C-HPP, http://www.C-HPP.org), is tasked with the understanding chromosome 19 functions at the gene and protein levels, as well as their roles in lung oncogenesis. Comparative genomic hybridization (CGH) studies revealed chromosome aberration in lung cancer subtypes, including ADC, SCC, LCC, and SCLC. The most common abnormality is 19p loss and 19q gain. Sixty-four aberrant genes identified in previous genomic studies and their encoded protein functions were further validated in the neXtProt database (http://www.nextprot.org/). Among those, the loss of tumor suppressor genes STK11, MUM1, KISS1R (19p13.3), and BRG1 (19p13.13) is associated with lung oncogenesis or remote metastasis. Gene aberrations include translocation t(15, 19) (q13, p13.1) fusion oncogene BRD4-NUT, DNA repair genes (ERCC1, ERCC2, XRCC1), TGFβ1 pathway activation genes (TGFB1, LTBP4), Dyrk1B, and potential oncogenesis protector genes such as NFkB pathway inhibition genes (NFKBIB, PPP1R13L) and EGLN2. In conclusion, neXtProt is an effective resource for the validation of gene aberrations identified in genomic studies. It promises to enhance our understanding of lung cancer oncogenesis.

KW - Antibodies

KW - Bioinformatics

KW - Genes

KW - Human disease

KW - Mass spectrometry

KW - mRNA

KW - Protein microarray

KW - Proteins

UR - http://www.scopus.com/inward/record.url?scp=84938417469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938417469&partnerID=8YFLogxK

U2 - 10.1007/s10555-015-9556-2

DO - 10.1007/s10555-015-9556-2

M3 - Article

VL - 34

SP - 217

EP - 226

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 2

ER -